Atrial fibrillation is an independent risk factor for new-onset myocardial infarction: a prospective study

References

• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128.
   PubMed Web of Science ®Google Scholar
• Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.
   PubMed Web of Science ®Google Scholar
• Camen S, Csengeri D, Geelhoed B, et al. Risk factors, subsequent disease onset, and prognostic impact of myocardial infarction and atrial fibrillation. J Am Heart Assoc. 2022;11(7):e024299.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med. 2014;174(1):107–114.
   PubMed Web of Science ®Google Scholar
• Bang CN, Gislason GH, Greve AM, et al. New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study. J Am Heart Assoc. 2014;3(1):e000382.
   PubMed Web of Science ®Google Scholar
• Jons C, Jacobsen UG, Joergensen RM, et al. The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy. Heart Rhythm. 2011;8(3):342–348.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Lopez F, O’Neal WT, et al. Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the atherosclerosis risk in communities (ARIC) study. Circulation. 2015;131(21):1843–1850.
   PubMed Web of Science ®Google Scholar
• Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257.
   PubMed Web of Science ®Google Scholar
• Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation. 2004;110(9):e82.
   PubMedGoogle Scholar
• Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines for the management of patients With unstable angina/non ST-Elevation myocardial infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007;116(7):e148.
   PubMed Web of Science ®Google Scholar
• Glazer NL, Smith NL, Heckbert SR, et al. Risk of myocardial infarction attributable to elevated levels of total cholesterol among hypertensives. Am J Hypertens. 2005;18(6):759–766.
   PubMed Web of Science ®Google Scholar
• Calling S, Johansson SE, Wolff M, et al. The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in women’s health in the lund area (WHILA): a 17-year follow-up cohort study. BMC Cardiovasc Disord. 2019;19(1):239.
   PubMed Web of Science ®Google Scholar
• Stevens RJ, Coleman RL, Adler AI, et al. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care. 2004;27(1):201–207.
   PubMed Web of Science ®Google Scholar
• Lee DY, Han K, Park S, et al. Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study. Cardiovasc Diabetol. 2020;19(1):144.
   PubMed Web of Science ®Google Scholar
• Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038–1045.
   PubMed Web of Science ®Google Scholar
• Batra G, Svennblad B, Held C, et al. All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart. 2016;102(12):926–933.
   PubMed Web of Science ®Google Scholar
• Li CY, Lin CP, Lin YS, et al. Newly diagnosed atrial fibrillation is an independent factor for future major adverse cardiovascular events. PLoS One. 2015;10(4):e0123211.
   PubMed Web of Science ®Google Scholar
• Lee HY, Yang PS, Kim TH, et al. Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study. Sci Rep. 2017;7(1):12716.
   PubMed Web of Science ®Google Scholar
• Bayturan O, Puri R, Tuzcu EM, et al. Atrial fibrillation, progression of coronary atherosclerosis and myocardial infarction. Eur J Prev Cardiolog. 2017;24(4):373–381.
   PubMed Web of Science ®Google Scholar
• Emdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ. 2016;532:h7013.
   PubMed Web of Science ®Google Scholar
• Liang F, Wang Y. Coronary heart disease and atrial fibrillation: a vicious cycle. Am J Physiol Heart Circ Physiol. 2021;320(1):h1–h12.
   PubMed Web of Science ®Google Scholar
• Iwasaki YK, Nishida K, Kato T, et al. Atrial fibrillation pathophysiology: implications for management. Circulation. 2011;124(20):2264–2274.
   PubMed Web of Science ®Google Scholar
• Wiecha J, Hombach V. Cellular electrophysiological properties in myocardial infarction. Eur Heart J. 1993;14:9–19.
   PubMed Web of Science ®Google Scholar
• Liehn EA, Postea O, Curaj A, et al. Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J Am Coll Cardiol. 2011;58(23):2357–2362.
   PubMed Web of Science ®Google Scholar
• Hadi HA, Alsheikh-Ali AA, Mahmeed WA, et al. Inflammatory cytokines and atrial fibrillation: current and prospective views. J Inflamm Res. 2010;3:75–97.
   PubMedGoogle Scholar
• Yilmaz R, Demirbag R, Durmus I, et al. Association of stage of left ventricular diastolic dysfunction with P wave dispersion and occurrence of atrial fibrillation after first acute anterior myocardial infarction. Ann Noninvasive Electrocardiol. 2004;9(4):330–338.
   PubMed Web of Science ®Google Scholar
• Wakili R, Voigt N, Kääb S, et al. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest. 2011;121(8):2955–2968.
   PubMed Web of Science ®Google Scholar
• Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J. 2012;33(15):1870–1877.
   PubMed Web of Science ®Google Scholar
• Louch WE, Mørk HK, Sexton J, et al. T-tubule disorganization and reduced synchrony of Ca2+ release in murine cardiomyocytes following myocardial infarction. J Physiol. 2006;574(2):519–533.
   PubMed Web of Science ®Google Scholar
• Lenaerts I, Bito V, Heinzel FR, et al. Ultrastructural and functional remodeling of the coupling between Ca2+ influx and sarcoplasmic reticulum Ca2+ release in right atrial myocytes from experimental persistent atrial fibrillation. Circ Res. 2009;105(9):876–885.
   PubMed Web of Science ®Google Scholar
• Palasubramaniam J, Wang X, Peter K. Myocardial infarction-from atherosclerosis to thrombosis. Arterioscler Thromb Vasc Biol. 2019;39(8):e176–e185.
   PubMed Web of Science ®Google Scholar
• Li K, Zemmrich C, Bramlage P, et al. Effect of ACEI and ARB treatment on nitric oxide-dependent endothelial function. Vasa. 2021;50(6):413–422.
   PubMed Web of Science ®Google Scholar
• Minamino T, Kitakaze M, Asanuma H, et al. Plasma adenosine levels and platelet activation in patients with atrial fibrillation. Am J Cardiol. 1999;83(2):194–198.
   PubMed Web of Science ®Google Scholar
• Matsue Y, Suzuki M, Abe M, et al. Endothelial dysfunction in paroxysmal atrial fibrillation as a prothrombotic state. Comparison with permanent/persistent atrial fibrillation. J Atheroscler Thromb. 2011;18(4):298–304.
   PubMed Web of Science ®Google Scholar
• Freestone B, Chong AY, Nuttall S, et al. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von willebrand factor and soluble E-selectin levels. Thromb Res. 2008;122(1):85–90.
   PubMed Web of Science ®Google Scholar
• Guazzi M, Belletti S, Bianco E, et al. Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion. Am J Physiol Heart Circ Physiol. 2006;291(2):H921–H928.
   PubMed Web of Science ®Google Scholar
• Shin SY, Na JO, Lim HE, et al. Improved endothelial function in patients with atrial fibrillation through maintenance of sinus rhythm by successful catheter ablation. J Cardiovasc Electrophysiol. 2011;22(4):376–382.
   PubMed Web of Science ®Google Scholar
• Willeit K, Kiechl S. Atherosclerosis and atrial fibrillation–two closely intertwined diseases. Atherosclerosis. 2014;233(2):679–681.
   PubMed Web of Science ®Google Scholar
• Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet. 2009;373(9658):155–166.
   PubMed Web of Science ®Google Scholar
• Choudhury A, Lip GY. Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb. 2003;33(5–6):282–289.
   PubMedGoogle Scholar
• Smeets MWJ, Mourik MJ, Niessen HWM, et al. Stasis promotes erythrocyte adhesion to von willebrand factor. Arterioscler Thromb Vasc Biol. 2017;37(9):1618–1627.
   PubMed Web of Science ®Google Scholar
• Hada M, Kaminski M, Bockenstedt P, et al. Covalent crosslinking of von willebrand factor to fibrin. Blood. 1986;68(1):95–101.
   PubMed Web of Science ®Google Scholar
• Mukamal KJ, Tolstrup JS, Friberg J, et al. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). Am J Cardiol. 2006;98(1):75–81.
   PubMed Web of Science ®Google Scholar
• Li-Saw-Hee FL, Blann AD, Gurney D, et al. Plasma von willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Eur Heart J. 2001;22(18):1741–1747.
   PubMed Web of Science ®Google Scholar
• Cortés GM, Viveros Sandoval ME, Areán Martínez CA, et al. Von willebrand factor plasma levels variability in nonvalvular atrial fibrillation. J Atr Fibrillation. 2014;7(4):1124.
   PubMedGoogle Scholar
• Lip GY, Lip PL, Zarifis J, et al. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation. 1996;94(3):425–431.
   PubMed Web of Science ®Google Scholar
• Sohara H, Amitani S, Kurose M, et al. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1997;29(1):106–112.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Takeshita K, Inden Y, et al. Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: involvement of mononuclear cell-platelet interaction. Thromb Res. 2011;128(6):e113–e118.
   PubMed Web of Science ®Google Scholar
• Otto A, Fareed J, Liles J, et al. Fibrinolytic deficit and platelet activation in atrial fibrillation and their postablation modulation. Clin Appl Thromb Hemost. 2018;24(5):803–807.
   PubMed Web of Science ®Google Scholar
• Khan AA, Lip GYH. The prothrombotic state in atrial fibrillation: pathophysiological and management implications. Cardiovasc Res. 2019;115(1):31–45.
   PubMed Web of Science ®Google Scholar
• Platonov PG, Mitrofanova LB, Orshanskaya V, et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol. 2011;58(21):2225–2232.
   PubMed Web of Science ®Google Scholar
• Akoum N, Fernandez G, Wilson B, et al. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(10):1104–1109.
   PubMed Web of Science ®Google Scholar
• Goldsmith I, Kumar P, Carter P, et al. Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. Am Heart J. 2000;140(5):777–784.
   PubMed Web of Science ®Google Scholar